Hansen Bjarne, Kvale Gerd, Hagen Kristen, Hjelle Kay M, Solem Stian, Bø Beate, Öst Lars-Göran
OCD-Team, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Psychology, University of Bergen, Bergen, Norway.
Front Psychol. 2018 Jun 26;9:1044. doi: 10.3389/fpsyg.2018.01044. eCollection 2018.
The current article reports on the findings from a pilot treatment study on panic disorder (PD) with or without agoraphobia. Consecutively referred patients were included and treated with the Bergen 4-day treatment format. Twenty-nine patients were included, primarily from unsuccessful treatment courses in the Norwegian specialist mental health care system, either ongoing or previously. Prior to treatment, only 34% were able to work but at 3-month follow-up 93% were able to do so. The proportion achieving reliable change on the panic severity measure was 76% post-treatment and 90% at follow-up. The remission rate was 72% at both assessments. These effects are significantly higher than those reported for six standard CBT studies in the literature using the same primary outcome measure (Panic Disorder Severity Scale). It is concluded that the Bergen 4-day treatment is a promising treatment approach for PD, and a randomized controlled trial is warranted.
本文报道了一项针对伴或不伴有广场恐惧症的惊恐障碍（PD）的试点治疗研究结果。连续转诊的患者被纳入研究，并采用卑尔根4天治疗模式进行治疗。共纳入29名患者，主要来自挪威专科心理健康护理系统中正在进行或之前未成功的治疗疗程。治疗前，只有34%的患者能够工作，但在3个月的随访中，这一比例为93%。在惊恐严重程度测量指标上实现可靠变化的比例在治疗后为76%，随访时为90%。两次评估的缓解率均为72%。这些效果显著高于文献中使用相同主要结局指标（惊恐障碍严重程度量表）的六项标准认知行为疗法研究报告的效果。研究得出结论，卑尔根4天治疗是一种有前景的惊恐障碍治疗方法，有必要进行随机对照试验。
